In this context, further investigation of the downstream of TLR2/4 mediated activation of p53/MDM2 oscillation in EpCAM+/ABCG2+ CSCs may provide new ways to activate p53 in tumor cells. The gene discussed is EPCAM; the disease is neoplasm.